• Earlier this week, Wall Street analysts projected that Teradyne would report quarterly earnings of $2.04 per share on revenues of US$1.22 billion, alongside growth expectations for its semiconductor test and industrial automation businesses.
• Soon after, the U.S. government’s decision to impose durable 10%–12.5% tariffs on major semiconductor trading partners introduced fresh concerns about Teradyne’s long-term cost structure and profitability profile.
• We’ll now examine how these new, durable U.S. tariffs on key semiconductor partners could reshape Teradyne’s existing investment narrative and risk balance.

Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

Teradyne Investment Narrative Recap

To own Teradyne, you need to believe in long-term demand for advanced chip and automation testing, particularly around AI and complex packaging. The immediate catalyst is whether upcoming results around the US$2.04 EPS and US$1.22 billion revenue mark confirm analysts’ expectations. The new 10% to 12.5% tariffs raise the main near term risk by potentially pressuring margins and customer spending, but they do not yet appear to fundamentally overturn the AI and semiconductor test thesis.

The most relevant recent announcement here is Teradyne’s guidance for Q2 2026, which called for US$1,150 million to US$1,250 million in revenue and US$1.83 to US$2.12 in GAAP diluted EPS. That outlook was set before tariffs were announced, so it now serves as a reference point for how much the new trade measures might affect both the near term earnings ramp and the company’s ability to manage its cost structure as AI focused demand develops.

Yet behind the AI test upside, the durability of margins under higher tariffs is something investors should be aware of...

Teradyne's narrative projects $7.0 billion revenue and $2.1 billion earnings by 2029. This requires 22.9% yearly revenue growth and an earnings increase of about $1.2 billion from $854.1 million today.

Uncover how Teradyne's forecasts yield a $416.65 fair value, a 19% upside to its current price.

Exploring Other Perspectives

While consensus focuses on strong AI test demand, the most bearish analysts already saw risk, even before tariffs, with revenue of about US$3.7 billion and earnings of roughly US$761 million by 2028, reminding you that views on Teradyne’s path can differ widely and may shift further as the new trade costs sink in.

Explore 5 other fair value estimates on Teradyne - why the stock might be worth as much as 57% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Teradyne research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Teradyne research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Teradyne's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.